Telomerase and the Immune System: The Enzyme That Prevents Chronic Diseases

For years, when we talked about telomeres, the story was almost always the same: at the end of each chromosome, there is a protective 'cap' that shortens slightly with each cell division, and when it becomes too short, the cell stops dividing or dies. Telomere length became a kind of 'biological clock,' and many biological age tests measure it. But this perspective, which focuses only on length, misses an important part of the picture.

A new study published in the journal Aging Cell (from the group of Prof. Mikhail Kolonin at UTHealth Houston) shifts the spotlight from the telomere itself to the enzyme that builds it: telomerase. And the surprising finding is that this enzyme plays a protective role specifically in immune cells of the myeloid type, primarily macrophages, and it does so in a manner completely independent of telomere length. When telomerase functions properly in these cells, they remain normal and balanced. When it is turned off, the cells 'age,' become inflammatory, and begin to accumulate fat, thereby accelerating the major chronic diseases of old age. This is not another article on 'how to lengthen telomeres,' but a deeper explanation of why the immune system ages, and what that does to the rest of the body.

What is Telomerase and How is it Different from Telomeres?

It's important to distinguish between the two concepts, as this is where most confusion arises:

Telomere is the physical structure: a repetitive DNA sequence (TTAGGG) at the end of a chromosome that protects it from erosion and from 'sticking' to other chromosomes.
Telomerase is the enzyme: a molecule that can add back those sequences lost during division, thereby restoring telomere length.
In most adult body cells, telomerase is almost turned off. Therefore, telomeres gradually shorten throughout life.
But in certain groups of cells, such as stem cells and immune system cells, telomerase remains actively controlled, because these cells must divide repeatedly throughout life.

This difference is the heart of the matter. A skin cell or a liver cell divides a limited number of times. But immune system cells must multiply rapidly each time the body is exposed to an infection, and then remain available for the next time. Without telomerase, they would 'wear out' after just a few infections. However, the new study reveals that telomerase also has a role in these cells that has nothing to do with telomere elongation, as we will see shortly.

The Connection to the Immune System: A Surprising Mechanism

The major novelty of the study concerns an additional and unexpected role of telomerase. The researchers created genetically engineered mice in which telomerase was turned off only in myeloid cells (the lineage from which macrophages are derived), without affecting the enzyme in the rest of the body. The natural expectation was that any problem, if it occurred, would stem from shortened telomeres. But what happened was completely different.

The macrophages of these mice 'aged' prematurely, entered a state of cellular senescence, and became inflammatory, yet their telomere length remained normal. In other words, the damage did not result from a short telomere. It resulted from another role of the enzyme: it turns out that telomerase has a non-classical activity within the mitochondria, the 'powerhouses' of the cell. When the enzyme is absent there, the energy production and metabolic balance of the macrophage are impaired, and the cell shifts to an inflammatory profile.

The practical outcome was dramatic. The 'aged' macrophages began to accumulate fat and became 'foam cells', those fat-laden cells that are a hallmark of atherosclerosis. The mice developed a disorder in their blood lipid profile (dyslipidemia), and when fed a high-calorie diet, they accumulated more body fat and suffered from impaired sugar metabolism. Even without a high-calorie diet, they developed lung scarring (pulmonary fibrosis) and signs of impaired heart function.

In other words, the story here is not 'a telomere that is too short' but rather an immune cell that has lost its metabolic balance, and therefore turned from a protector into a source of damage. In this way, the study joins a growing body of research showing that telomerase has functions beyond telomere elongation.

It's important to remember the broader context of immune aging. When immune cells age, they begin to secrete inflammatory molecules (such as IL-6 and TNF-alpha) chronically, even when there is no threat. This phenomenon is part of what scientists call inflammaging, a combination of 'inflammation' and 'aging': a low-grade chronic inflammation that accompanies aging and accelerates almost every disease of old age.

Current Evidence

Study 1: Turning Off Telomerase in Macrophages (Mice, 2026)

The new study in Aging Cell is the centerpiece of the story, and it's important to emphasize: this is a study in mice, not in humans. The researchers showed that turning off telomerase specifically in myeloid cells caused macrophages to become inflammatory and turn into foam cells, leading to dyslipidemia, pulmonary fibrosis, and impaired heart function. The central novelty is twofold: first, the protection does not stem from telomere length (telomeres remained normal); second, it is mediated by a mitochondrial role of telomerase. A finding in mice does not guarantee the same thing happens in humans, but it offers a new and precise mechanism that can be tested.

Study 2: Old Immune Cells and Inflammatory Cytokine Secretion

Previous work in the field has shown that 'aged' immune cells adopt an inflammatory secretion profile. Studies have found that in adults over 65, a higher proportion of 'senescent' immune cells in the blood is linked to higher levels of inflammatory markers like CRP and IL-6, and these in turn are linked to heart disease and early mortality. This is the background upon which the new finding about macrophages rests.

Study 3: Telomerase Mutations and Diseases at a Young Age

Evidence from the opposite side comes from rare syndromes in humans. People with inherited mutations that impair telomerase (such as in Dyskeratosis Congenita) suffer from immune failure and bone marrow failure at a particularly young age, sometimes in their second or third decade of life. This is living human proof that without functional telomerase, the maintenance system of blood and immune cells collapses early.

Population Data

Large cohort studies have found a consistent link between short telomeres in white blood cells and an increased risk of disease. A leading meta-analysis (Haycock and colleagues, BMJ 2014, across about 24 studies) found that people in the bottom third of telomere length in blood cells showed a ~54% higher risk of coronary heart disease (relative risk 1.54) compared to the top third, even after adjusting for standard risk factors.

What is the Connection to Inflammaging and Major Diseases?

The chronic inflammation generated by aged immune cells is not a local problem. It spreads throughout the body via the bloodstream and fuels the three major chronic diseases of aging:

Cardiovascular disease: Chronic inflammation, and especially macrophages turning into foam cells, accelerates the formation of atherosclerotic plaque in arteries. The IL-6 and TNF secreted by aged immune cells contribute to plaque instability. The new finding about foam cells directly illustrates this link.
Type 2 diabetes: Systemic inflammation impairs insulin sensitivity. Inflammaging is one of the factors that explains why insulin resistance increases with age even in lean individuals. In the study mice, turning off telomerase in macrophages indeed impaired sugar metabolism under a high-calorie diet.
Dementia and neurodegenerative diseases: Chronic systemic inflammation is linked to neuroinflammation in the brain, which accelerates the accumulation of amyloid plaques and cognitive decline.

In other words: functional deterioration of immune cells is not just 'a problem of the immune system'. It is an open tap of inflammation that leaks into every system in the body. This is why understanding this mechanism is so important; it is a central hub from which seemingly unrelated diseases branch out.

Does This Mean We Should 'Take' Telomerase?

Here we need to stop and take a deep breath, because this is the point where many health articles fail. The temptation is clear: if the decline of telomerase causes all this harm, then why not simply boost telomerase? The answer is that boosting telomerase is a dangerous double-edged sword, and not for a theoretical reason.

The Problem: Cancer Got Here First

The main reason telomerase is turned off in most body cells is built-in protection against cancer. A cell whose telomeres shorten loses the ability to divide indefinitely, and this is a natural brake on cancerous growth. Indeed, about 85-90% of cancerous tumors reactivate telomerase to become 'immortal' and divide endlessly. In other words, the enzyme that the immune system needs to stay healthy is the same enzyme that cancer hijacks to thrive.

Why a 'Telomerase Pill' is Not a Solution

Systemic and blanket activation of telomerase throughout the body could remove one of the most important safety brakes against cancer. Any supplement or 'telomerase activator' that promises to lengthen telomeres in all cells indiscriminately should be met with extreme caution. The marketing promise ignores the deep biological reason why evolution 'chose' to turn off the enzyme.

The Real Scientific Direction

What this study offers is not 'take telomerase,' but understanding. If the critical role of telomerase in immune cells is specifically in the mitochondria and not in telomere elongation, then the future goal may not be flooding the body with telomerase, but rather targeted restoration of mitochondrial function in immune cells, in a way that restores balance without opening the door to cancer. This is a delicate biological engineering challenge, and it is still years away and at the stage of mouse research. Until then, any 'shortcut' approach is more dangerous than beneficial.

What Can We Take from the Study?

Don't chase after 'telomerase activators' in supplements. Science still doesn't know how to activate telomerase safely and in a targeted manner, and marketing promises ignore the cancer risk. This is one of those areas where a 'supplement' is not equivalent to 'safe.'
Focus on reducing chronic inflammation through proven methods. If the real problem is inflammaging, you can attack it directly: a diet rich in omega-3s, reducing sugar and processed carbohydrates, and quality sleep lower systemic inflammatory markers.
Regular physical activity keeps immune cells young. Studies show that aerobic and resistance training are linked to longer telomeres in white blood cells and functionally 'younger' immune cells, without any supplement.
Maintain a healthy weight and metabolic health. Abdominal fat tissue itself secretes inflammatory cytokines and accelerates inflammaging. Weight loss reduces inflammation.
If you suspect early or unusual immune failure, see a doctor. Extreme immune decline at a young age could be a sign of rare telomerase syndromes, and this has diagnostic significance.

The Broader Perspective

The story of telomerase in immune cells is a perfect example of how aging is not one process, but a network of intertwined mechanisms. We've told you quite a bit about telomere length as a 'clock,' but this study reminds us that the clock is only part of the picture. The other part, perhaps the more important one, is function: not just how long the telomere is, but whether the enzyme responsible for maintaining it also fulfills its other roles, such as in the mitochondria, where needed.

The immune system is a central hub. When it ages, it not only protects us less against infections and cancer, it itself becomes a source of inflammation that accelerates all other aging. This is why many researchers believe that 'rejuvenating' the immune system may be one of the most powerful levers for extending healthspan, more than any single supplement.

And finally, the sobering message: The same mechanism that keeps cells healthy is the same mechanism that cancer hijacks to become immortal. Aging, it turns out, is not a simple glitch that can be 'turned off.' It is sometimes an evolutionary compromise, a price we pay in exchange for protection against something worse. This understanding, not the search for shortcuts, is the responsible way forward.

References:
Gao Z, Yu Y, Wiggins D, Sevick-Muraca EM, Kolonin MG. Telomerase Knockout in Myeloid Cells Predisposes Mice to Foam Cell Formation, Dyslipidemia, Lung Fibrosis, and Cardiac Dysfunction. Aging Cell, 2026. DOI: 10.1111/acel.70490
UTHealth Houston press release (27 May 2026): New Study Reveals Role for Telomerase in Immune Cells Preventing Chronic Disease